This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Digene last week denied allegations made by Third Wave Technologies early last month that the company had “abused its monopoly power to thwart competition” in the HPV diagnostics market, and it asked the court to dismiss the charges.
Third Wave’s allegations were made in a countersuit that is part of the firms’ ongoing dispute over a Digene patent covering an HPV diagnostic test.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.